FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Sandoz Recalls 1 Cefazolin Lot

FDA says Sandoz has recalled one lot of Cefazolin for injection following a customer complaint that vials of another drug were included in a Cefazolin...

Medical Devices

FDA Clears Philips SmartSpeed Precise Software

FDA clears Philips SmartSpeed Precise AI-enhanced software for MRI systems.

latest-news-card-1
Human Drugs

Myelodysplastic Syndrome Drug Development Guide

FDA publishes a draft guidance to assist sponsors in developing drugs to treat myelodysplastic syndromes.

latest-news-card-1
Biologics

Positive Phase 3 Results for Moderna Flu Vaccine

Moderna says its mRNA-1010 investigational seasonal flu vaccine achieved very positive results in a Phase 3 efficacy trial.

latest-news-card-1
Human Drugs

Bioresearch Monitoring Violations by Dr. Peter Michael

FDA warns Hialeah, FL-based physician Peter Michael about failing to follow the investigation plan in two clinical studies.

latest-news-card-1
Human Drugs

Regenerons Lynozyfic Approved for Some Myelomas

FDA gives accelerated approval to Regenerons Lynozyfic for some multiple myelomas.

latest-news-card-1
Biologics

InVia Fertility Specialists HCT/Ps Violations

FDA warns Hoffman Estates, IL-based InVia Fertility Specialists about multiple violations of regulations governing human cells, tissues, and cellular ...

latest-news-card-1
Human Drugs

Healwell Homeo Private Selling Adulterated Drugs: FDA

FDA warns Indias Healwell Homeo Private Limited about producing adulterated homeopathic and OTC drugs with CGMP violations.

latest-news-card-1
Medical Devices

Contec and Epsimed Cybersecurity Patch

FDA says Contec has issued a software patch that resolves cybersecurity vulnerabilities in certain Contec and Epsimed patient monitors by removing net...

latest-news-card-1
Human Drugs

FDA: Website Selling Misbranded, Unapproved Drugs

FDA warns the owners of the www.buynetmeds.com Web site about selling misbranded and unapproved drug products in interstate commerce.